Dolby Laboratories Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.4B+6.3% YoYTTM through 26 Jun 2026
Net Income $226.2M-13.6% YoYTTM through 26 Jun 2026
Free Cash Flow $392.7MTTM through 26 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 88.7% |
| EBITDA Margin | 24.5% |
| Operating Margin | 28.1% |
| Net Margin | 16.7% |
Returns
8.8%ROE
7.2%ROA
11.8%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio2.97x
Net Debt-$594.7Mnet cash position
Cash & Equivalents$669.4M
Quality Metrics
Altman Z-Score8.00
Piotroski F-Score6 / 9
FCF Margin29.0%
Rule of 4033.8
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $1.3B
Diluted EPS$2.35TTMFY2025: $2.62
Dividend
$0.72Per share, FY20262.74%Yield-4.6%5-yr growth
Capital Allocation
R&D Spend$265.9M
Capex Intensity3.3%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.